Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-20-000782
Filing Date
2020-03-13
Accepted
2020-03-13 16:31:24
Documents
10
Effectiveness Date
2020-03-13

Document Format Files

Seq Description Document Type Size
1 c95418_defa14a.htm DEFA14A 32631
2 GRAPHIC x1_c95418x1x1.jpg GRAPHIC 12310
3 GRAPHIC x1_c95418x1x2.jpg GRAPHIC 2146
4 GRAPHIC x1_c95418x1x3.jpg GRAPHIC 3842
5 GRAPHIC x1_c95418x1x4.jpg GRAPHIC 2899
6 GRAPHIC x1_c95418x1x5.jpg GRAPHIC 2179
7 GRAPHIC x1_c95418x1x6.jpg GRAPHIC 2776
8 GRAPHIC x1_c95418x1x7.jpg GRAPHIC 1272
9 GRAPHIC x1_c95418x1x8.jpg GRAPHIC 1162
10 GRAPHIC x1_c95418x1x9.jpg GRAPHIC 1383
  Complete submission text file 0000930413-20-000782.txt   76281
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-03619 | Film No.: 20713172
SIC: 2834 Pharmaceutical Preparations